Pushpal Banerjee, DO
Emergency Medicine · Tampa, FLNPI 1669428371
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,063 of the $19,744 with a category attached, or 76.3%. 11 manufacturers reported payments, led by AstraZeneca at 46.6% of the total. Reporting peaked in 2020 at $9,311 and has fallen 96.8% since, to $294 in 2025. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $243.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$9K
- Portola Pharmaceuticals, LLC$7K
- Acelrx Pharmaceuticals, Inc.$2K
- ZOLL Medical Corporation$933
- Philips North America LLC$188
- Teleflex LLC$183
- plus $461 from 5 others
What the payments were for
- Speaking & faculty fees$15,06376%
- Travel & lodging$1,3787%
- Food & beverage$3,30417%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 29 | $9,193 |
| Portola Pharmaceuticals, LLC | 20 | $6,786 |
| Acelrx Pharmaceuticals, Inc. | 1 | $2,000 |
| ZOLL Medical Corporation | 17 | $933 |
| Philips North America LLC | 3 | $188 |
| Teleflex LLC | 4 | $183 |
| Stryker | 2 | $158 |
| Boston Scientific | 2 | $127 |
| Chiesi USA, Inc. | 1 | $112 |
| Amgen | 1 | $48 |
| CSL Behring | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,744 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 25 | $248 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $245 |
| Methylprednisolone | 33 | $236 |
| Ketorolac Tromethamine | 15 | $220 |
| Azithromycin | 34 | $129 |
| Ondansetron OdtOndansetron | 16 | $128 |
| Levofloxacin | 24 | $96 |
| Metronidazole | 14 | $85 |
| Dicyclomine Hcl | 14 | $65 |
| Cyclobenzaprine Hcl | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Tampa
- Jason WilsonTampa$538K
- Juan GallegoTampa$73K
- David WeinTampa$22K
- Rodolfo LoureiroTampa$7K
- Michael LozanoTampa$5K
- Laurent DreyfussSunrise$1.2M
- Robert LutenJacksonville$190K
- Adam LeisyHialeah$148K
- Joseph TyndallGainesville$130K
- Kunal AgarwalMiami$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.